EP2132228
CD37 ónæmismeðferðarefni og samsetning með tvívirku efnameðferðarefni þar af
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.4.2009EP published:
22.6.2011EP application number:
09707110.4
EP translation filed:
23.8.2011Grant published:
15.9.2011EPO information:
European Patent Register
Max expiry date:
10.4.2029Expiry date:
10.4.2021
Title:
CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF
Timeline
Today
11.4.2009EP application
22.6.2011EP Publication
23.8.2011Translation submitted
15.9.2011Registration published
10.4.2021Expires
Owner
Name:
Emergent Product Development Seattle, LLCAddress:
2273 Research Boulevard, Suite 400, 20850, Rockville, MD, US
Inventor
Name:
TAN, PhilipAddress:
Lynnwood, WA, US
Name:
SIMON, Sandy, AlexanderAddress:
Seattle, WA, US
Name:
BRADY, WilliamAddress:
Bothell, WA, US
Name:
LEDBETTER, Jeffrey, A.Address:
Shoreline, WA, US
Name:
HAYDEN-LEDBETTER, Martha, SusanAddress:
Shoreline, WA, US
Name:
MORALES, CecileAddress:
Seattle, WA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
190067 PDate:
11.4.2008Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, C12N 15/02, A61K 31/4184, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 21.3.2012
Expires: 10.4.2013
Payer: Sigurjónsson & Thor ehf.
Number: 5
Paid: 19.3.2013
Expires: 10.4.2014
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 18.3.2014
Expires: 10.4.2015
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 18.3.2015
Expires: 10.4.2016
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.3.2016
Expires: 10.4.2017
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 7.3.2017
Expires: 10.4.2018
Payer: Árnason Faktor
Number: 10
Paid: 5.3.2018
Expires: 10.4.2019
Payer: Árnason Faktor
Number: 11
Paid: 8.3.2019
Expires: 10.4.2020
Payer: Árnason Faktor
Number: 12
Paid: 10.3.2020
Expires: 10.4.2021
Payer: Árnason Faktor ehf.